United States · FDA National Drug Code directory

Aleve

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0280-6080_4526c253-b571-1d84-e063-6394a90ae3f9
Product NDC
0280-6080
Form
CAPSULE, LIQUID FILLED
Composition / generic term
Naproxen Sodium
Labeler
Bayer HealthCare LLC.
Marketing category
NDA
Marketing start / end (source format)
20070220
Source listing expiry
20261231

Source-listed ingredients

  • NAPROXEN SODIUM — 220 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (0280-6080-01) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE · 0280-6080-01
  • 2 BOTTLE in 1 PACKAGE, COMBINATION (0280-6080-02) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE · 0280-6080-02
  • 1 BOTTLE, PLASTIC in 1 CARTON (0280-6080-04) / 50 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0280-6080-04
  • 160 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0280-6080-16) · 0280-6080-16
  • 1 BOTTLE, PLASTIC in 1 CARTON (0280-6080-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0280-6080-20
  • 1 BOTTLE, PLASTIC in 1 CARTON (0280-6080-40) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0280-6080-40
  • 1 BOTTLE, PLASTIC in 1 CARTON (0280-6080-80) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 0280-6080-80

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →